164 related articles for article (PubMed ID: 6142750)
1. Neurochemical characteristics of early and late onset types of Alzheimer's disease.
Rossor MN; Iversen LL; Reynolds GP; Mountjoy CQ; Roth M
Br Med J (Clin Res Ed); 1984 Mar; 288(6422):961-4. PubMed ID: 6142750
[TBL] [Abstract][Full Text] [Related]
2. Gamma-aminobutyric acid concentration in brain tissue at two stages of Alzheimer's disease.
Lowe SL; Francis PT; Procter AW; Palmer AM; Davison AN; Bowen DM
Brain; 1988 Aug; 111 ( Pt 4)():785-99. PubMed ID: 3401683
[TBL] [Abstract][Full Text] [Related]
3. A post-mortem study of the cholinergic and GABA systems in senile dementia.
Rossor MN; Garrett NJ; Johnson AL; Mountjoy CQ; Roth M; Iversen LL
Brain; 1982 Jun; 105(Pt 2):313-30. PubMed ID: 7082992
[TBL] [Abstract][Full Text] [Related]
4. Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques.
Katzman R; Terry R; DeTeresa R; Brown T; Davies P; Fuld P; Renbing X; Peck A
Ann Neurol; 1988 Feb; 23(2):138-44. PubMed ID: 2897823
[TBL] [Abstract][Full Text] [Related]
5. Alzheimer's disease: choline acetyltransferase activity in brain tissue from clinical and pathological subgroups.
Bird TD; Stranahan S; Sumi SM; Raskind M
Ann Neurol; 1983 Sep; 14(3):284-93. PubMed ID: 6227276
[TBL] [Abstract][Full Text] [Related]
6. Significance of neurotransmitter abnormalities in Alzheimer's disease.
Katzman R; Brown T; Fuld P; Thal L; Davies P; Terry R
Res Publ Assoc Res Nerv Ment Dis; 1986; 64():279-86. PubMed ID: 2873637
[No Abstract] [Full Text] [Related]
7. Cortical somatostatin-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type.
Davies P; Terry RD
Neurobiol Aging; 1981; 2(1):9-14. PubMed ID: 6115327
[TBL] [Abstract][Full Text] [Related]
8. Age and histopathologic heterogeneity in Alzheimer's disease. Evidence for subtypes.
Bondareff W; Mountjoy CQ; Roth M; Rossor MN; Iversen LL; Reynolds GP
Arch Gen Psychiatry; 1987 May; 44(5):412-7. PubMed ID: 2883954
[TBL] [Abstract][Full Text] [Related]
9. Serotonergic pathology is not widespread in Alzheimer patients without prominent aggressive symptoms.
Procter AW; Francis PT; Stratmann GC; Bowen DM
Neurochem Res; 1992 Sep; 17(9):917-22. PubMed ID: 1357564
[TBL] [Abstract][Full Text] [Related]
10. Cortical substance P-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type.
Crystal HA; Davies P
J Neurochem; 1982 Jun; 38(6):1781-4. PubMed ID: 6176686
[TBL] [Abstract][Full Text] [Related]
11. Intralaminar neurochemical distributions in human midtemporal cortex: comparison between Alzheimer's disease and the normal.
Perry EK; Atack JR; Perry RH; Hardy JA; Dodd PR; Edwardson JA; Blessed G; Tomlinson BE; Fairbairn AF
J Neurochem; 1984 May; 42(5):1402-10. PubMed ID: 6142924
[TBL] [Abstract][Full Text] [Related]
12. A post-mortem study of noradrenergic, serotonergic and GABAergic neurons in Alzheimer's disease.
Reinikainen KJ; Paljärvi L; Huuskonen M; Soininen H; Laakso M; Riekkinen PJ
J Neurol Sci; 1988 Mar; 84(1):101-16. PubMed ID: 2452858
[TBL] [Abstract][Full Text] [Related]
13. Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment.
Francis PT; Palmer AM; Sims NR; Bowen DM; Davison AN; Esiri MM; Neary D; Snowden JS; Wilcock GK
N Engl J Med; 1985 Jul; 313(1):7-11. PubMed ID: 2582256
[TBL] [Abstract][Full Text] [Related]
14. Cortical somatostatin, neuropeptide Y, and NADPH diaphorase neurons: normal anatomy and alterations in Alzheimer's disease.
Kowall NW; Beal MF
Ann Neurol; 1988 Feb; 23(2):105-14. PubMed ID: 2897822
[TBL] [Abstract][Full Text] [Related]
15. Neurochemical activities in human temporal lobe related to aging and Alzheimer-type changes.
Perry EK; Blessed G; Tomlinson BE; Perry RH; Crow TJ; Cross AJ; Dockray GJ; Dimaline R; Arregui A
Neurobiol Aging; 1981; 2(4):251-6. PubMed ID: 6174877
[TBL] [Abstract][Full Text] [Related]
16. Topographical distribution of neurochemical changes in Alzheimer's disease.
Procter AW; Lowe SL; Palmer AM; Francis PT; Esiri MM; Stratmann GC; Najlerahim A; Patel AJ; Hunt A; Bowen DM
J Neurol Sci; 1988 Apr; 84(2-3):125-40. PubMed ID: 2898011
[TBL] [Abstract][Full Text] [Related]
17. Neurotransmitter changes in Alzheimer's disease: implications to diagnostics and therapy.
Reinikainen KJ; Soininen H; Riekkinen PJ
J Neurosci Res; 1990 Dec; 27(4):576-86. PubMed ID: 1981917
[TBL] [Abstract][Full Text] [Related]
18. Brain choline acetyltransferase activity and neuropeptide Y concentrations in Alzheimer's disease.
Foster NL; Tamminga CA; O'Donohue TL; Tanimoto K; Bird ED; Chase TN
Neurosci Lett; 1986 Jan; 63(1):71-5. PubMed ID: 3754039
[TBL] [Abstract][Full Text] [Related]
19. Neocortical morphometry, lesion counts, and choline acetyltransferase levels in the age spectrum of Alzheimer's disease.
Hansen LA; DeTeresa R; Davies P; Terry RD
Neurology; 1988 Jan; 38(1):48-54. PubMed ID: 3336463
[TBL] [Abstract][Full Text] [Related]
20. Senile dementia and presenile dementia.
Nakamura S
Tohoku J Exp Med; 1990 Aug; 161 Suppl():49-60. PubMed ID: 1707190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
